HIV :: European License for Roche HIV Drug Viracept Recommended for Reinstatement
Roche announced that the European Medicines Agency’s (EMEA) Committee for Human Medicinal Products (CHMP) has recommended that Viracept’s marketing authorization is re-instated in Europe following its suspension earlier this summer.